These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27 related articles for article (PubMed ID: 17209243)
1. New formulation of saquinavir (Fortovase) is more effective. Tam CW Fac Notes (New Orleans La); 1998; 10(2):11. PubMed ID: 11365126 [TBL] [Abstract][Full Text] [Related]
2. Saquinavir (Fortovase or Invirase). Res Initiat Treat Action; 2000 Mar; 6(1):24-5. PubMed ID: 11708182 [No Abstract] [Full Text] [Related]
3. Anti-HIV agents. Saquinavir--switching from Fortovase to Invirase. TreatmentUpdate; 2004; 16(3):8-9. PubMed ID: 17219608 [No Abstract] [Full Text] [Related]
5. Anti-HIV agents. A protease-only regimen--Kaletra and saquinavir. TreatmentUpdate; 2004; 16(3):8. PubMed ID: 17216837 [No Abstract] [Full Text] [Related]
6. Drug interactions. Coming soon--a new formulation of saquinavir (Invirase). TreatmentUpdate; 2006; 18(3):9. PubMed ID: 17209243 [No Abstract] [Full Text] [Related]
7. Saquinavir, the pioneer antiretroviral protease inhibitor. la Porte CJ Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1313-22. PubMed ID: 19737048 [TBL] [Abstract][Full Text] [Related]
8. Saquinavir. Porche DJ J Assoc Nurses AIDS Care; 1996; 7(4):61-4. PubMed ID: 8875367 [No Abstract] [Full Text] [Related]
9. [The new saquinavir formulation SGC (Soft Gel Capsule)]. Katlama C Presse Med; 1999 Apr; 28(15):815-8. PubMed ID: 10325942 [No Abstract] [Full Text] [Related]
11. Saquinavir: From HIV to COVID-19 and Cancer Treatment. Pereira M; Vale N Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883499 [TBL] [Abstract][Full Text] [Related]
12. Overview of boosted protease inhibitors in treatment-experienced HIV-infected patients. Youle M J Antimicrob Chemother; 2007 Dec; 60(6):1195-205. PubMed ID: 17890281 [TBL] [Abstract][Full Text] [Related]